Discover › Program page

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health active

Rounds we have recorded

1. Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

   National Institutes of Health Grant Amount not stated Total pool (not per award): Estimated total program funding (Grants.gov)

   The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as...

   Open

   Application 2026-11-10 exact time to be confirmed about 6 days

   Verified: 2026-11-04 · Official page ↗

   ☆ Save